Business Description
bioXXmed AG
ISIN : DE000A41YD32
Total Employee Number:
1Compare
Compare
Traded in other countries / regions
T5O.Germany IPO Date
2007-05-18Description
bioXXmed AG is an investment and holding company in the technology sector. It originated from CytoTools GmbH, a successful German technology enterprise from the pharmaceuticals and medical products field.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.53 | |||||
Debt-to-Equity | 385 | |||||
Debt-to-EBITDA | -1.08 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -131.91 | |||||
Beneish M-Score | -3.97 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -15.4 | |||||
3-Year EBITDA Growth Rate | 42.2 | |||||
3-Year EPS without NRI Growth Rate | 48.6 | |||||
3-Year Book Growth Rate | -97.2 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 20.65 | |||||
9-Day RSI | 21.47 | |||||
14-Day RSI | 22.21 | |||||
3-1 Month Momentum % | -27.43 | |||||
6-1 Month Momentum % | -3.53 | |||||
12-1 Month Momentum % | -60.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 103 | |||||
Quick Ratio | 103 | |||||
Cash Ratio | 68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -33.2 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -1594.12 | |||||
Net Margin % | -2147.06 | |||||
EBITDA Margin % | -2105.88 | |||||
ROE % | -286.65 | |||||
ROA % | -86.77 | |||||
ROIC % | -123.74 | |||||
3-Year ROIIC % | -2.83 | |||||
ROC (Joel Greenblatt) % | -730.61 | |||||
ROCE % | -93.23 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 12.22 | |||||
PB Ratio | 192.5 | |||||
EV-to-EBIT | -1.09 | |||||
EV-to-EBITDA | -1.09 | |||||
EV-to-Revenue | 23 | |||||
Price-to-GF-Value | 0.07 | |||||
Earnings Yield (Greenblatt) % | -91.74 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
bioXXmed AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.017 | ||
| EPS (TTM) (€) | -1.344 | ||
| Beta | 16.1733 | ||
| 3-Year Sharpe Ratio | 0.41 | ||
| 3-Year Sortino Ratio | 2.52 | ||
| Volatility % | 1135.83 | ||
| 14-Day RSI | 22.21 | ||
| 14-Day ATR (€) | 0.004345 | ||
| 20-Day SMA (€) | 0.796 | ||
| 12-1 Month Momentum % | -60.19 | ||
| 52-Week Range (€) | 0.005 - 2.75 | ||
| Shares Outstanding (Mil) | 0.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
bioXXmed AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
bioXXmed AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| 0.2:1 Stock Split | 2026-01-14 | 0.85 (+0.00%) | ||
| 0.1:1 Stock Split | 2024-08-12 | 12.01 (+0.00%) |
Show
Entries
bioXXmed AG Frequently Asked Questions
What is bioXXmed AG(FRA:T5O)'s stock price today?
The current price of FRA:T5O is €0.77. The 52 week high of FRA:T5O is €2.75 and 52 week low is €0.01.
When is next earnings date of bioXXmed AG(FRA:T5O)?
The next earnings date of bioXXmed AG(FRA:T5O) is .
Does bioXXmed AG(FRA:T5O) pay dividends? If so, how much?
bioXXmed AG(FRA:T5O) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on bioXXmed AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers